Picture of Voyager Therapeutics logo

VYGR — Voyager Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Voyager Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

* Voyager Therapeutics Inc  VYGR.OQ  reported quarterly
adjusted
earnings of $1.25​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -61 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 29 cents per
share. Wall Street expected results to range from -62 cents
to $1.33 per share.
    * Revenue rose 5,910.4% to $90.06 million from a year ago;
analysts expected $20.64 million. 
    * Voyager Therapeutics Inc's reported EPS for the quarter
was
$1.25​.
    * The company reported quarterly net income of $56.4
million.
    * Voyager Therapeutics Inc shares had risen by 5.6% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 50.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $16.00 
This summary was machine generated from LSEG data February 28 at
11:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.29          1.25           Beat
 Sep. 30 2023      -0.58          -0.59          Missed
 Jun. 30 2023      -0.57          -0.51          Beat
 Mar. 31 2023      0.77           2.94           Beat

Recent news on Voyager Therapeutics

See all news